Exploring Serum Bilirubin as a Potential Biomarker for Primary Open-Angle Glaucoma
DOI:
https://doi.org/10.26877/asset.v8i3.2383Keywords:
serum bilirubin, oxidative stress, biomarkers, severity of POAGAbstract
Total bilirubin (TBIL) functions as a natural antioxidant, and its levels tend to decrease with increasing oxidative stress, including in glaucoma tissue. This study aims to explore the relationship between total serum bilirubin levels and the severity of primary open-angle glaucoma (POAG). A total of 25 POAG patients and 25 control subjects further divided into aged >60 years and ≤60 years from the Glaucoma Clinic of the Universitas Sumatera Utara Hospital and its affiliated hospitals were included, consisting of 4 patients with moderate disease and 21 with advanced disease. Serum TBIL levels were measured and analyzed using the Mann-Whitney test. Results showed an average TBIL of 0.23 mg/dL in moderate cases and 0.37 mg/dL in advanced cases, with no significant relationship between TBIL and POAG severity (p=0.131). These findings indicate that total serum bilirubin levels are not related to POAG severity and are likely not a reliable clinical biomarker for glaucoma.
References
[1] E. Kosior-Jarecka and A. Grzybowski, “Retinal Ganglion Cell Replacement in Glaucoma Therapy: A Narrative Review,” 2024. doi: https://doi.org/10.3390/jcm13237204
[2] Z. Si et al., “The role of RGC degeneration in the pathogenesis of glaucoma,” Int. J. Biol. Sci., vol. 21, no. 1, p. 211, 2025, doi: http://doi.org/10.7150/ijbs.103222.
[3] T. Dada et al., “Ocular and systemic factors associated with glaucoma,” J. Curr. Glaucoma Pract., vol. 16, no. 3, p. 179, 2022, [Online]. Available: http://doi.org/10.5005/jp-journals-10078-1383
[4] J. Y. Lee, M. H. Cho, J. Lee, and J. S. Lee, “Association Between Intraocular Pressure and Risk Factors for Metabolic Syndrome in Korea,” J. Korean Med. Sci., vol. 40, no. 33, 2025, doi: https://doi.org/10.3346/jkms.2025.40.e202.
[5] J. S. Imperato, K. H. Zou, J. Z. Li, and T. A. Hassan, “Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence,” Patient Prefer. Adherence, vol. 16, no. null, pp. 2213–2227, Jan. 2022, doi: https://doi.org/10.2147/PPA.S367443.
[6] M. Lin et al., “Primary Open-Angle Glaucoma Diagnosis from Optic Disc Photographs Using a Siamese Network,” Ophthalmol. Sci., vol. 2, no. 4, p. 100209, 2022, doi: https://doi.org/10.1016/j.xops.2022.100209.
[7] Y. Wang, Y. Guo, Y. Zhang, S. Huang, and Y. Zhong, “Differences and Similarities Between Primary Open Angle Glaucoma and Primary Angle-Closure Glaucoma,” Eye Brain, vol. 16, no. null, pp. 39–54, Dec. 2024, doi: https://doi.org/10.2147/EB.S472920
[8] K. M. Maidenko, “Primary open angle glaucoma: mechanisms of pathogenesis and genetic predisposition. Review,” Med. Sci. Ukr., vol. 18, no. 2, pp. 89–102, 2022, doi: https://doi.org/10.32345/2664-4738.2.2022.11.
[9] D. J. Hurley, C. Normile, M. Irnaten, and C. O’Brien, “The Intertwined Roles of Oxidative Stress and Endoplasmic Reticulum Stress in Glaucoma,” Antioxidants, vol. 11, no. 5, p. 886, 2022, doi: https://doi.org/10.3390/antiox11050886.
[10] L. Vítek et al., “Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis,” 2022. doi: https://doi.org/10.3390/antiox11112118.
[11] K. Prabhavathi, M. Kunder, K. N. Shashidhar, K. Kanthamani, and A. Raveesha, “Serum Total Bilirubin and Oxidative Stress Status in Diabetic Retinopathy–A Hospital-Based Observational Study,” Biomed. Pharmacol. J., vol. 17, no. 2, pp. 1317–1327, 2024, doi: https://doi.org/10.13005/bpj/2945.
[12] M. Shao et al., “Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study,” Oxid. Med. Cell. Longev., vol. 2023, no. 1, p. 8206298, Jan. 2023, doi: https://doi.org/10.1155/2023/8206298
[13] Y. Dong et al., “Association between total bilirubin and gender-specific incidence of fundus arteriosclerosis in a Chinese population: a retrospective cohort study,” Sci. Rep., vol. 13, no. 1, p. 11244, 2023, doi: https://doi.org/10.1038/s41598-023-38378-1.
[14] B. C. Umezurike, M. O. Akhimien, O. Udeala, U. G. Green, U. Okpechi-Agbo, and M. U. Ohaeri, “Primary open angle glaucoma: the pathophysiolgy, mechanisms, future diagnostic and therapeutic directions,” Ophthalmol. Res. An Int. J., vol. 10, no. 3, pp. 1–17, 2019, doi: https://doi.org/10.9734/or/2019/v10i330106.
[15] R. Parikh, N. Kitnarong, J. B. Jonas, S. R. Parikh, and R. Thomas, “Optic disc morphology in primary open-angle glaucoma versus primary angle-closure glaucoma in South India,” Indian J. Ophthalmol., vol. 69, no. 7, 2021, doi: https://doi.org/10.4103/ijo.IJO_2442_20.
[16] T. Liu et al., “The impact of intraocular pressure fluctuations on the progression of glaucoma and associated factors,” Adv. Ophthalmol. Pract. Res., vol. 5, no. 2, pp. 142–148, 2025, doi: https://doi.org/10.1016/j.aopr.2025.03.002.
[17] R. E. Iorga, A. D. Moraru, D. Costin, R. S. Munteanu-Dănulescu, and D. C. Brănișteanu, “Current trends in targeting the oxidative stress in glaucoma,” Eur. J. Ophthalmol., vol. 34, no. 2, pp. 328–337, 2024, doi: https://doi.org/10.1177/11206721231214297.
[18] S. Tabak, S. Schreiber-Avissar, and E. Beit-Yannai, “Crosstalk between MicroRNA and Oxidative Stress in Primary Open-Angle Glaucoma,” 2021. doi: https://doi.org/10.3390/ijms22052421.
[19] A. H. Kim, D.-H. Son, M.-E. Moon, S. Jeon, H. S. Lee, and Y.-J. Lee, “Sex differences in the relationship between serum total bilirubin and risk of incident metabolic syndrome in community-dwelling adults: Propensity score analysis using longitudinal cohort data over 16 years,” Cardiovasc. Diabetol., vol. 23, no. 1, p. 92, 2024, doi: https://doi.org/10.1186/s12933-024-02182-6.
[20] G. A. P. Deva, N. M. A. Suryathi, and I. M. A. Kusumadjaja, “Prevalensi Glaukoma Sudut Terbuka Primer Di Rsup Sanglah Periode Juni 2017 – Juni 2018,” E-Jurnal Med. Udayana, vol. 9, no. 5, pp. 61–66, 2020, [Online]. Available: https://ojs.unud.ac.id/index.php/eum/article/view/70655/38456
[21] N. Zhang, J. Wang, Y. Li, and B. Jiang, “Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review,” Sci. Rep., vol. 11, no. 1, p. 13762, 2021, doi: https://doi.org/10.1038/s41598-021-92971-w.
[22] M. Rizk, A. Grise-Dulac, and D. Gatinel, “Glaucoma in women: What do we know so far - A systematic review,” AJO Int., vol. 1, no. 1, p. 100013, 2024, doi: https://doi.org/10.1016/j.ajoint.2024.100013.
[23] S. Yolanda, Y. Primitasari, and D. R. Sari, “Characteristics of Primary Open-Angle Glaucoma Patients in Dr. Soetomo General Hospital Surabaya,” Eye, vol. 11, pp. 19–26, 2020, doi: https://doi.org/10.20473/juxta.V12I12021.6-9.
[24] J. M. O’Brien et al., “Family History in the Primary Open-Angle African American Glaucoma Genetics Study Cohort,” Am. J. Ophthalmol., vol. 192, pp. 239–247, 2018, doi: https://doi.org/10.1016/j.ajo.2018.03.014.
[25] H. Youngblood, M. A. Hauser, and Y. Liu, “Update on the genetics of primary open-angle glaucoma,” Exp. Eye Res., vol. 188, p. 107795, 2019, doi: https://doi.org/10.1016/j.exer.2019.107795.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Advance Sustainable Science Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
